Lannett reported $-77962000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Amerisourcebergen ABC:US $ 541.5M 238.66M
Ani Pharmaceuticals ANIP:US $ -12913000 6.28M
Aurora Cannabis Inc ACB:CN -624576000 371.76M
Canopy Growth Corp WEED:CN C$ -1838229000 1.3B
Cardinal Health CAH:US 36M 133M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Depomed DEPO:US $ 10.79M 0.77M
Knight Therapeutics Inc GUD:CN C$ 2.89M 2.93M
Lannett LCI:US $ -77.96M 55.88M
Ligand Pharmaceuticals LGND:US $ -0.47M 7.34M
Mckesson MCK:US $ 1036M 403M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Novartis NVS:US $ 2228M 624M
Omeros OMER:US $ -37438000 2.39M
Pacira Pharmaceuticals PCRX:US $ 31.24M 13.84M
Perrigo Ordinary Shares PRGO:US $ -16.2M 37.9M
Pfizer PFE:US $ 12102M 2229M
Prestige Brands PBH:US $ 87.01M 9.59M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical TEVA:IT -949000000 236M
Zoetis ZTS:US $ 670M 57M